Wisconsin AB43: An Act to amend 450.095 (title) and 450.095 (3); to create 49.46 (2) (bg), 450.01 (16) (L), 450.095 (1) (ag) and (ar) and 450.095 (2m) of the statutes; Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)

What the bill says

To amend 450.095 (title) and 450.095 (3); to create 49.46 (2) (bg), 2450.01 (16) (L), 450.095 (1) (ag) and (ar) and 450.095 (2m) of the statutes; 3relating to: permitting pharmacists to prescribe certain contraceptives, 4extending the time limit for emergency rule procedures, providing an 5exemption from emergency rule procedures, granting rule-making authority, 6and providing a penalty…

From the introduced text, February 17, 2025:

to amend 450.095 (title) and 450.095 (3); to create 49.46 (2) (bg), 2450.01 (16) (L), 450.095 (1) (ag) and (ar) and 450.095 (2m) of the statutes; 3relating to: permitting pharmacists to prescribe certain contraceptives, 4extending the time limit for emergency rule procedures, providing an 5exemption from emergency rule procedures, granting rule-making authority, 6and providing a penalty. Analysis by the Legislative Reference Bureau This bill permits a pharmacist to prescribe and dispense hormonal contraceptive patches and self-administered oral hormonal contraceptives, subject to limitations described as follows. The bill requires the Pharmacy Examining Board, after consultation with the Medical Examining Board, the Board of Nursing, and the Department of Health Services, to promulgate rules to establish standard procedures for the prescribing of contraceptives by pharmacists under the bill. The rules must require that pharmacists use a self-assessment questionnaire, developed in consideration of guidelines established by the American Congress of Obstetricians and Gynecologists, when prescribing a contraceptive. The self-assessment questionnaire must state and the patient must acknowledge on the self-assessment questionnaire that a hormonal contraceptive patch or a self-administered oral hormonal contraceptive is not protection against sexually transmitted diseases, and that it is strongly recommended that the patient annually meet with a physician or other medical professional to discuss the patient's prescribed hormonal contraceptive treatment and other routine preventive care. Under the bill, …